Veerhealth Care Ltd. Approves Preferential Allotment of Warrants
Veerhealth Care Ltd. announced on March 28, 2026, that its Board of Directors approved the issuance and allotment of Fully Convertible Warrants on a preferential basis, aggregating up to Rs. 21,00,00,000 (Rupees Twenty One Crores Only).The warrants will be issued to individuals belonging to the Promoter & Promoter Group Category and Non-Promoter Category. The issue price will be determined by the Board or a Committee of Directors in accordance with applicable regulations.
The proposed allottees and their respective allotment amounts are as follows:
| S.No. | Name of the Proposed Allottee | Category | Amount in Rs. (upto) |
|---|---|---|---|
| 1 | Ruchi Yogesh Shah | Promoter | 1,43,85,000.00 |
| 2 | Shruti Akash Shah | Promoter | 1,45,32,000.00 |
| 3 | Yogesh Mahasuklal Shah | Promoter | 2,62,50,000.00 |
| 4 | Yogesh Shah HUF | Promoter | 1,89,00,000.00 |
| 5 | Mahasuklal Shah HUF | Promoter | 94,50,000.00 |
| 6 | Krupa Harsh Jain | Promoter | 1,17,60,000.00 |
| 7 | Akash Lalabhai Patel | Non-Promoter | 2,64,60,000.00 |
| 8 | Kusumben Hirala Shah | Non-Promoter | 2,94,21,000.00 |
| 9 | Ria Shah | Non-Promoter | 2,94,21,000.00 |
| 10 | Panna Pankaj Bhai Shah | Non-Promoter | 2,94,21,000.00 |
| Total | Total | Total | 21,00,00,000.00 |
Warrant holders have the right to convert these warrants into fully paid-up equity shares with a face value of Rs. 10 each, within 18 months from the date of allotment.
Additionally, the Board constituted a Preferential Issue Committee and approved the draft of the Postal Ballot Notice for shareholder approval.
The Board meeting commenced at 3:00 P.M. and concluded at 4:00 P.M.
The proposed allottees will pay an amount equivalent to at least 25% of the Warrant Issue Price, with the balance payable upon exercising the warrants.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.